tiprankstipranks
Trending News
More News >
HYTN Innovations Inc (TSE:HYTN)
:HYTN

HYTN Innovations Inc (HYTN) AI Stock Analysis

Compare
4 Followers

Top Page

TSE:HYTN

HYTN Innovations Inc

(HYTN)

Select Model
Select Model
Select Model
Neutral 46 (OpenAI - 5.2)
,
Neutral 46 (OpenAI - 5.2)
,
Neutral 46 (OpenAI - 5.2)
,
Neutral 46 (OpenAI - 5.2)
,
Neutral 46 (OpenAI - 5.2)
,
Neutral 46 (OpenAI - 5.2)
,
Neutral 46 (OpenAI - 5.2)
,
Neutral 46 (OpenAI - 5.2)
,
Neutral 46 (OpenAI - 5.2)
,
Neutral 46 (OpenAI - 5.2)
,
Neutral 46 (OpenAI - 5.2)
,
Neutral 46 (OpenAI - 5.2)
,
Neutral 46 (OpenAI - 5.2)
Rating:46Neutral
Price Target:
C$0.25
▼(-5.77% Downside)
Action:ReiteratedDate:03/19/26
The score is primarily held down by weak financial performance—very thin margins, heavy losses, and negative equity—despite strong TTM revenue growth and improved (but still negative) free cash flow. Technicals are mixed/neutral and provide only modest support, while valuation is constrained by negative earnings and no dividend data.
Positive Factors
Revenue Growth
A ~75.6% TTM revenue rebound to ~$2.94M demonstrates improving commercial traction and durable demand. Persistent top-line growth increases the chance to leverage fixed costs, supports scale economics, and creates a clearer path to profitability if margins are addressed.
Improving Operating Cash Flow
Operating cash flow moving to slightly positive from prior-period burn reflects better cash conversion and operational control. This structural improvement lengthens runway, reduces near-term financing pressure, and allows management to prioritize margin and growth initiatives over emergency liquidity needs.
Lean Cost Structure (Low Headcount)
A very small workforce (7 employees) implies a lean operating model with low fixed payroll overhead. This structural lightness enables faster scaling of revenue to operating results, flexibility in reallocating resources, and lower ongoing cash burn in capital-constrained periods.
Negative Factors
Very Thin Margins
Extremely thin gross margin (~5.6%) and a net margin near -91% reveal structural profitability issues. Even with strong revenue growth, such low margins mean scale alone may not deliver profitability without material product mix, pricing, or cost-of-goods improvements, posing a lasting hurdle.
Negative Shareholders' Equity
Negative shareholders' equity (~-$1.24M TTM) signals impaired capitalization and weak balance-sheet resilience. It restricts access to non-dilutive capital, elevates counterparty and refinancing risk, and reduces strategic flexibility for investments or M&A over the medium term.
Negative Free Cash Flow
Persistent negative free cash flow (≈-$0.01M TTM), despite improved operating cash flow, shows the business is not yet self-funding. Ongoing negative FCF necessitates external financing, increasing dilution or leverage risk and constraining sustainable reinvestment in margins or growth initiatives.

HYTN Innovations Inc (HYTN) vs. iShares MSCI Canada ETF (EWC)

HYTN Innovations Inc Business Overview & Revenue Model

Company DescriptionHYTN Innovations Inc. engages in the research, production, marketing, distribution, and sale of cannabis products for recreational consumers in Canada. It intends to offer infused sparkling beverages and infused edibles in various flavors. The company is headquartered in Vancouver, Canada.
How the Company Makes Moneynull

HYTN Innovations Inc Financial Statement Overview

Summary
Revenue rebounded strongly TTM (~+75.6% to ~$2.94M), but profitability remains very weak (gross margin ~5.6%, net margin roughly -91%) and the balance sheet is pressured by negative shareholders’ equity (TTM about -$1.24M). Cash flow improved to slightly positive operating cash flow (~$0.01M), but free cash flow is still negative (about -$0.01M).
Income Statement
18
Very Negative
TTM (Trailing-Twelve-Months) revenue rebounded strongly to ~$2.94M (about +75.6%), showing improving commercial traction. However, profitability remains weak: gross margin is ~5.6% and the company is still deeply loss-making (net margin roughly -91%), with negative operating results as well. Overall, strong top-line momentum is outweighed by persistently poor margins and continued net losses.
Balance Sheet
12
Very Negative
The balance sheet is pressured by negative shareholders’ equity in the most recent periods (TTM equity about -$1.24M), which is a key financial risk and suggests limited balance-sheet flexibility. Debt is moderate in absolute dollars (~$1.10M TTM), but leverage is effectively high given the equity deficit. Assets have also declined versus the prior annual period, reinforcing a weaker capitalization profile despite some year-to-year variability in debt levels.
Cash Flow
22
Negative
Cash generation is mixed. TTM (Trailing-Twelve-Months) operating cash flow is slightly positive (~$0.01M), a notable improvement from prior annual periods that showed sizable cash burn. However, free cash flow remains negative (about -$0.01M TTM), indicating the business is not yet consistently self-funding, and prior-year volatility in cash flow underscores execution and funding risk.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Sep 2021
Income Statement
Total Revenue1.67M851.49K763.46K696.36K0.00
Gross Profit93.23K287.44K91.85K121.65K0.00
EBITDA-1.12M-6.26M-1.45M-9.88M-745.51K
Net Income-1.52M-6.61M-2.33M-17.38M-959.48K
Balance Sheet
Total Assets3.62M2.38M2.58M3.79M2.76M
Cash, Cash Equivalents and Short-Term Investments345.10K256.58K187.56K1.03M264.06K
Total Debt2.04M793.56K919.74K887.22K2.58M
Total Liabilities4.74M2.56M2.27M1.71M2.77M
Stockholders Equity-1.12M-172.97K314.72K2.07M-8.88K
Cash Flow
Free Cash Flow-590.49K-804.21K-1.18M-2.38M-1.67M
Operating Cash Flow-572.27K-783.36K-1.18M-2.16M-693.52K
Investing Cash Flow-15.92K162.67K-4.10K2.19M-1.02M
Financing Cash Flow676.12K689.71K346.17K727.93K1.80M

HYTN Innovations Inc Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.26
Price Trends
50DMA
0.25
Negative
100DMA
0.19
Positive
200DMA
0.19
Positive
Market Momentum
MACD
>-0.01
Positive
RSI
44.11
Neutral
STOCH
21.58
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:HYTN, the sentiment is Negative. The current price of 0.26 is above the 20-day moving average (MA) of 0.25, above the 50-day MA of 0.25, and above the 200-day MA of 0.19, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 44.11 is Neutral, neither overbought nor oversold. The STOCH value of 21.58 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:HYTN.

HYTN Innovations Inc Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
46
Neutral
C$20.62M-16.25-9999.00%47.86%-225.43%
46
Neutral
C$3.55M-1.41-25.05%-19.86%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:HYTN
HYTN Innovations Inc
0.22
0.05
29.41%
TSE:CGII
CleanGo Innovations
0.49
0.19
61.67%
TSE:HYPE
Hemp for Health Inc
0.18
0.05
38.46%
TSE:MUSL
Element Nutritional Sciences Inc
0.04
-0.03
-42.86%
TSE:PTFY
Plantify Foods Inc
0.10
-0.31
-76.25%

HYTN Innovations Inc Corporate Events

Business Operations and Strategy
HYTN Hires German Firm MCS to Boost Investor-Focused Marketing
Positive
Jan 10, 2026

HYTN Innovations Inc. has engaged Germany-based MCS Market Communication Service GmbH to deliver a roughly 60-day marketing and communications program aimed at increasing investor and market awareness of the cannabis-focused pharmaceutical manufacturer. MCS, which is independent from HYTN and does not hold its securities, will be paid €50,000 in cash to review and refine HYTN’s existing materials, develop digital content and advertising, optimize keywords, and coordinate online campaigns targeting relevant investor audiences, signaling a focused push by HYTN to strengthen its visibility and positioning in regulated cannabis and psychoactive compounds markets.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 19, 2026